CYTOKINETICS INC — Director's Dealing 2023

Mar 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-03-06

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-06	Common Stock	F	4958	$39.13	Disposed	135183	Direct

Footnotes

F1: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023 and does not represent a sale by the reporting person.